{"entity":{"type":"insider","cik":"0001825322","url":"/insider/0001825322","json_url":"/insider/0001825322.json","name":"Rangwala Reshma","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2023-04-24","last":"2026-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Rangwala Reshma","source":"filing","n_filings":9,"first_seen":"2023-04-24","last_seen":"2026-05-15"}],"transactions":[{"id":6153792,"accession":"0001193125-26-226685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-226685","line_url":"/filing/0001193125-26-226685#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":408.0,"shares_display":"408","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":3876.0,"total_display":"3,876.00","total_whole":"3,876","shares_owned_after":56829.0,"shares_owned_after_display":"56,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider"},{"id":5759152,"accession":"0001825322-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001825322-26-000006","line_url":"/filing/0001825322-26-000006#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":449.0,"shares_display":"449","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":4014.06,"total_display":"4,014.06","total_whole":"4,014","shares_owned_after":56290.0,"shares_owned_after_display":"56,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-21","filed_date":"2026-04-22","scope":"insider"},{"id":6141782,"accession":"0001825322-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001825322-26-000003","line_url":"/filing/0001825322-26-000003#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5066.0,"shares_display":"5,066","price_per_share":9.4095,"price_display":"9.41","price_state":"stated","total_value":47668.527,"total_display":"47,668.53","total_whole":"47,669","shares_owned_after":56739.0,"shares_owned_after_display":"56,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":4845153,"accession":"0001193125-25-205044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-205044","line_url":"/filing/0001193125-25-205044#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":408.0,"shares_display":"408","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":2623.44,"total_display":"2,623.44","total_whole":"2,623","shares_owned_after":29390.0,"shares_owned_after_display":"29,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider"},{"id":4713442,"accession":"0000950170-25-058137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-058137","line_url":"/filing/0000950170-25-058137#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":419.0,"shares_display":"419","price_per_share":6.17,"price_display":"6.17","price_state":"stated","total_value":2585.23,"total_display":"2,585.23","total_whole":"2,585","shares_owned_after":28853.0,"shares_owned_after_display":"28,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-23","filed_date":"2025-04-24","scope":"insider"},{"id":4376508,"accession":"0000950170-25-034732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-034732","line_url":"/filing/0000950170-25-034732#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3587.0,"shares_display":"3,587","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":22562.23,"total_display":"22,562.23","total_whole":"22,562","shares_owned_after":29272.0,"shares_owned_after_display":"29,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":2676815,"accession":"0000950170-24-046871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-046871","line_url":"/filing/0000950170-24-046871#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6789.0,"shares_display":"6,789","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":7943.13,"total_display":"7,943.13","total_whole":"7,943","shares_owned_after":342931.0,"shares_owned_after_display":"342,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-22","filed_date":"2024-04-23","scope":"insider"},{"id":3213693,"accession":"0000950170-24-025193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-025193","line_url":"/filing/0000950170-24-025193#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5969.0,"shares_display":"5,969","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":7162.8,"total_display":"7,162.80","total_whole":"7,163","shares_owned_after":349720.0,"shares_owned_after_display":"349,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider"},{"id":3213686,"accession":"0000950170-24-025193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-025193","line_url":"/filing/0000950170-24-025193#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15667.0,"shares_display":"15,667","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":18330.39,"total_display":"18,330.39","total_whole":"18,330","shares_owned_after":355689.0,"shares_owned_after_display":"355,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":8544812,"accession":"0001209191-23-025464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-025464","line_url":"/filing/0001209191-23-025464","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001825322","owner_name":"Rangwala Reshma","owner_display_name":"Rangwala Reshma","owner_url":"/insider/0001825322","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6770.0,"shares_display":"6,770","price_per_share":4.0496042097488925,"price_display":"4.05","price_state":"stated","total_value":27415.8205,"total_display":"27,415.82","total_whole":"27,416","shares_owned_after":158230.0,"shares_owned_after_display":"158,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-24","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (EVP & Chief Medical Officer)","n_filings":9,"first_seen":"2023-04-24","last_seen":"2026-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001825322","retrieved_at":"2026-08-27T06:20:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}